Client satisfaction is our biggest priority. We cater to our clients needs and provide mutual funds in multiple share classes. All our portfolios follow the same process to fulfill our goal of generating long term alpha. Learn more about our research process.
| QTD | YTD | One Year | Three Years |
Five Years |
Since Inception 3/31/2014 |
|
|---|---|---|---|---|---|---|
| Pzena Emerging Markets Value Fund Institutional Class – PZIEX | 5.87% | 20.71% | 20.71% | 6.69% | 7.84% | 4.43% |
| Pzena Emerging Markets Value Fund Investor Class – PZVEX | 5.82% | 20.30% | 20.30% | 6.35% | 7.48% | 4.11% |
| MSCI Emerging Markets Index | 7.86% | 9.83% | 9.83% | -5.08% | 3.68% | 2.78% |
| MSCI Emerging Markets Value Index | 8.05% | 14.21% | 14.21% | -0.01% | 3.37% | 2.07% |
| PZIEX Expense Ratio: Gross: 1.15%, Net: 1.08%* Go to Footnote | ||||||
| PZVEX Expense Ratio: Gross: 1.50%, Net: 1.43%* Go to Footnote |
The MSCI Emerging Markets Index is a free float-adjusted market capitalization index that is designed to measure equity market performance of emerging markets, and provides equity returns including dividends net of withholding tax rates as calculated by MSCI. The MSCI Emerging Markets Value Index captures large and mid-cap emerging markets securities exhibiting overall value style characteristics. The value investment style characteristics for index construction are defined using three variables: book value to price, 12-month forward earnings to price and dividend yield. You cannot invest directly in an index.
Fund holdings, Regional and Sector exposures and characteristics are as of the date shown and are subject to change at any time. As a result, the Fund’s current and future holdings, Regional and Sector exposures and characteristics may vary substantially from the information shown. No recommendation is made regarding the advisability of buying or selling any security.
The Morningstar Rating™ for funds, or “star rating”, is calculated for managed products (including mutual funds, variable annuity and variable life subaccounts, exchange-traded funds, closed-end funds, and separate accounts) with at least a three-year history, without adjustment for sales loads. Exchange-traded funds and open-ended mutual funds are considered a single population for comparative purposes. It is calculated based on a Morningstar Risk-Adjusted Return measure that accounts for variation in a managed products monthly excess performance, placing more emphasis on downward variations and rewarding consistent performance. The top 10% of products in each product category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars, and the bottom 10% receive 1 star. The Overall Morningstar Rating for a managed product is derived from a weighted average of the performance figures associated with its three-, five-, and 10-year (if applicable) Morningstar Rating metrics. The weights are: 100% three-year rating for 36-59 months of total returns, 60% five-year rating/40% three-year rating for 60-119 months of total returns, and 50% 10-year rating/30% five-year rating/20% three-year rating for 120 or more months of total returns. While the 10-year overall star rating formula seems to give the most weight to the 10-year period, the most recent three-year period actually has the greatest impact because it is included in all three rating periods. PZIEX was rated against the following numbers of Diversified Emerging Markets Funds over the following time periods: 744 funds in the last three years; 654 funds in the last five years. With respect to these Diversified Emerging Markets Funds, PZIEX received a Morningstar Rating of 5 stars for the three-year period and 4 stars for the five-year period. The rating is specific to PZIEX and does not apply to other share classes of the Fund. © 2023 Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.
Before you invest in Pzena Funds, please refer to the statutory and summary prospectuses for important information about the investment company, including investment objectives, risks, charges and expenses. You may also obtain a hard copy of the prospectuses by calling 1-844-PZN-1996 (1-844-796-1996) or by clicking on statutory prospectus or summary prospectus . The prospectuses should be read carefully before you invest or send money.
Mutual fund investing involves risk. Principal loss is possible. Investments in foreign securities involve political, economic and currency risks, greater volatility and differences in accounting methods. These risks are greater for investments in Emerging Markets. The fund may have emphasis on a specific sector which could adversely affect a fund to a greater extent than if its emphasis was less. The fund may invest in securities which are less liquid and more difficult to sell than more liquid securities. Investments in REITs are subject to the risks associated with the direct ownership of real estate. The Fund emphasizes a “value” style of investing, which targets undervalued companies with characteristics for improved valuations. This style of investing is subject to the risk that the valuations never improve or that the returns on “value” securities may not move in tandem with the returns on other styles of investing or the stock market in general.
Pzena Funds are offered only to United States residents, and information on this site is intended only for such persons. Nothing on this web site should be considered a solicitation to buy or an offer to sell shares of the Fund in any jurisdiction where the offer or solicitation would be unlawful under the securities laws of such jurisdiction.
Investments in REITs are subject to the risks associated with the direct ownership of real estate.
The Pzena Funds are distributed by Quasar Distributors, LLC.